Search results
Showing 61 to 75 of 101 results for dexamethasone
Ixazomib with lenalidomide and dexamethasone for untreated multiple myeloma [ID1170]
Discontinued [GID-TA10254]
Multiple myeloma - carfilzomib (with lenalidomide and dexamethasone, after prior therapy) [ID677]
Discontinued [GID-TAG511]
Evidence-based recommendations on using coronary artery stents in adults.
Evidence-based recommendations on brolucizumab (Beovu) for diabetic macular oedema in adults.
Discontinued [GID-TA10353]
Managed access allows patients to access promising new treatments that would otherwise not be recommended because it is too uncertain whether the treatment is cost-effective.
This guideline covers managing and monitoring diabetic retinopathy in people under the care of hospital eye services. This includes non-proliferative and proliferative diabetic retinopathy, and diabetic macular oedema.
Dexamethasone and hydrocortisone are both corticosteroids; they have a role in treating COVID-19 in certain people.
In development [GID-TA10926] Expected publication date: TBC
Discontinued [GID-TA10502]
Evidence-based recommendations on axicabtagene ciloleucel (Yescarta) for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapy.
Evidence-based recommendations on aflibercept (Eylea) for treating sight problems caused by diabetic macular oedema in adults.
Evidence-based recommendations on pemetrexed (Alimta) for locally advanced or metastatic non-squamous non-small-cell lung cancer in adults who have had pemetrexed and cisplatin.